Clinical Trial Update: Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating sequential intensive chemotherapy followed by reduced-intensity conditioning for patients with refractory or relapsed acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Lymphoblastic Leukemia, Acute, Adult | Phase 2 | Status: UNKNOWN